These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28628929)

  • 1. [Who Should Provide Persons with Familial Risk of Colorectal Cancer with Information on Early Detection? - The View of those Affected].
    Plath J; Siebenhofer A; Schulz-Rothe S; Güthlin C
    Gesundheitswesen; 2018 Oct; 80(10):878-881. PubMed ID: 28628929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
    Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
    BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients.
    Courtney RJ; Paul CL; Carey ML; Sanson-Fisher RW; Macrae FA; D'Este C; Hill D; Barker D; Simmons J
    BMC Cancer; 2013 Jan; 13():13. PubMed ID: 23305355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of colonoscopy and colonoscopic findings among individuals aged 40-54 years with a positive family history of colorectal cancer: a cross-sectional study in general practice.
    Plath J; Siebenhofer A; Haug U; Koné I; Hechtner M; Blumenstein I; Schulz-Rothe S; Gerlach FM; Guethlin C
    Eur J Cancer Prev; 2018 Nov; 27(6):539-545. PubMed ID: 28692588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of a First-Degree Relative With Colorectal Cancer and Uptake of Screening Among Persons 40 to 54 Years Old.
    Weigl K; Tikk K; Hoffmeister M; Hampe J; Igel S; Kolligs F; Klug SJ; Mansmann U; Müller O; Nagel JM; Pichler M; Schwab M; Schweigler D; Stephan AM; De Toni EN; Brenner H
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2535-2543.e3. PubMed ID: 31809916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR.
    Hoffmann S; Crispin A; Lindoerfer D; Sroczynski G; Siebert U; Mansmann U; Consortium F
    BMC Gastroenterol; 2020 May; 20(1):131. PubMed ID: 32370777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a screening questionnaire for familial and hereditary colorectal cancer risk work in a health insurance population?
    Pieper C; Kolankowska I; Jöckel KH
    Eur J Cancer Care (Engl); 2012 Nov; 21(6):758-65. PubMed ID: 22587639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual- and provider-level factors associated with colorectal cancer screening in accordance with guideline recommendation: a community-level perspective across varying levels of risk.
    Courtney RJ; Paul CL; Sanson-Fisher RW; Macrae FA; Carey ML; Attia J; McEvoy M
    BMC Public Health; 2013 Mar; 13():248. PubMed ID: 23514586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer risk assessment and screening recommendation: a community survey of healthcare providers' practice from a patient perspective.
    Courtney RJ; Paul CL; Sanson-Fisher RW; Macrae FA; Carey ML; Attia J; McEvoy M
    BMC Fam Pract; 2012 Mar; 13():17. PubMed ID: 22414115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol of the RaPS study: novel risk adapted prevention strategies for people with a family history of colorectal cancer.
    Tikk K; Weigl K; Hoffmeister M; Igel S; Schwab M; Hampe J; Klug SJ; Mansmann U; Kolligs F; Brenner H
    BMC Cancer; 2018 Jul; 18(1):720. PubMed ID: 29976178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Roos VH; Mangas-Sanjuan C; Rodriguez-Girondo M; Medina-Prado L; Steyerberg EW; Bossuyt PMM; Dekker E; Jover R; van Leerdam ME
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2657-2667.e9. PubMed ID: 31525516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of a positive family history of colorectal cancer in general practice: a cross-sectional study.
    Plath J; Siebenhofer A; Koné I; Hechtner M; Schulz-Rothe S; Beyer M; Gerlach FM; Guethlin C
    Fam Pract; 2017 Feb; 34(1):30-35. PubMed ID: 27920116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
    Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer.
    Kallenberg FG; IJspeert JE; Bossuyt PM; Aalfs CM; Dekker E
    Fam Cancer; 2015 Sep; 14(3):401-10. PubMed ID: 25800523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer?
    Bronner K; Mesters I; Weiss-Meilnik A; Geva R; Rozner G; Strul H; Inbar M; Halpern Z; Kariv R
    Fam Cancer; 2013 Dec; 12(4):629-37. PubMed ID: 23546820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculating the Starting Age for Screening in Relatives of Patients With Colorectal Cancer Based on Data From Large Nationwide Data Sets.
    Tian Y; Kharazmi E; Brenner H; Xu X; Sundquist K; Sundquist J; Fallah M
    Gastroenterology; 2020 Jul; 159(1):159-168.e3. PubMed ID: 32251666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
    Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC
    Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CONTRIBUTION OF FAMILY MEDICINE TO COLORECTAL CANCER PREVENTION AND EARLY DETECTION; FORTY-YEAR EXPERIENCE OF FAMILY MEDICINE DEPARTMENT, OSIJEK HEALTH CENTER].
    Ebling Z
    Acta Med Croatica; 2015 Nov; 69(4):373-80. PubMed ID: 29084381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.